Cardinal Health (CAH) Tops Q3 EPS by 7c, Miss on Revenue; Reaffirms FY EPS Guidance at Bottom of Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cardinal Health (CAH) PT Raised to $78 at Evercore ISI
May 1, 2017 11:05 AM EDTEvercore ISI bumped its price target on Cardinal Health (NYSE: CAH) modestly to $78.00 (from $77.50) while maintaining a Outperform rating following Q1 results.
Analyst Ross Muken said while the company didn't have any new surprises, they view Pharma momentum as slightly above... More
Tigress Financial Partners Starts Cardinal Health (CAH) at Neutral
April 30, 2017 2:30 PM EDTTigress Financial Partners initiates coverage on Cardinal Health (NYSE: CAH) with a Neutral rating.
Analyst Ivan Feinseth says the company has "extremely low" Economic Operating Cash Flow and Economic Profit margin while acknowledging the company's strong revenue growth. He sees low margins... More
